Average Co-Inventor Count = 5.82
ph-index = 2
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. National Institute of Health and Medical Research (6 from 1,835 patents)
2. Université De Lille 2 Droit Et Santé (3 from 13 patents)
3. Alzprotect (3 from 4 patents)
4. Sanofi (1 from 1,464 patents)
5. Innogenetics N.v. (1 from 82 patents)
6. Centre Hospitalier Regional Et Universitaire De Lille (Chru) (1 from 9 patents)
7. Universite Du Droit Et De La Santa-Lille Ii (1 from 1 patent)
8. Universite De Lille 2 Droit Et Saute (1 from 1 patent)
9. Centre National De La Recherche Scientifique (5,111 patents)
10. Ecole Superieure De Physique Et De Chimie Industrielles De La Ville De Paris (100 patents)
11. Université De Lille (58 patents)
12. Centre Hospitalier Régional Universitaire De Lille (25 patents)
13. Centre Hospitalier Régional Et Universitaire De Lille (1 patent)
14. Inserm (0 patent)
15. Universite Du Droit Et De La Sante - Lille Ii (0 patent)
7 patents:
1. 10807958 - 1,4-bis(3-aminopropyl)piperazine derivative and its use
2. 10772884 - Sulphate salts of N-(3-(4-(3-(diisobutylamino)propyl)piperazin-1-yl)propyl)-1H-benzo[d]imidazol-2-amine, preparation thereof and use of the same
3. 10537569 - Sulphate salts of N-(3-(4-(3-(diisobutylamino)propyl)piperazin-1-yl)propyl)-1H-benzo[d]imidazol-2-amine, preparation thereof and use of the same
4. 10017476 - 1,4-bis(3-aminopropyl)piperazine derivative and its use
5. 9562018 - Sulphate salts of N-(3-(4-(3-(diisobutylamino)propyl)piperazin-1-yl)propyl)-1H-benzo[d]imidazol-2-amine, preparation thereof and use of the same
6. 9044478 - Use of 1,4-bis (3-aminoalkyl) piperazine derivatives in the treatment of neurodegenerative diseases
7. 8343493 - Antibodies specific of the β-amyloid peptides and their uses as diagnostic agents or drugs